• Normal maturation of human natural killer cells requires the expression of TOX2.
Key points
• Normal maturation of human natural killer cells requires the expression of TOX2.
• TOX2 directly regulates the expression of T-BET during human natural killer cell development.
Abstract
Thymocyte selection-associated high mobility group box protein family member 2 (TOX2) is a transcription factor belonging to the TOX family that shares a highly conserved high mobility group DNA binding domain with the other TOX members.
While TOX1 has been shown to be an essential regulator of T-cell and natural killer (NK) cell differentiation in mice, little is known about the roles of the other TOX family members in lymphocyte development, particularly in humans. In this study, we found that TOX2 was preferentially expressed in mature human NK cells and was . This process is regulated intrinsically through the transcription factor network in NK cells and extrinsically by cytokine-mediated cell-to-cell communication [2] [3] [4] . The cytokine IL-15, which is produced mainly by phagocytes and dendritic cells, is known to play a pivotal role in NK cell maturation, survival, and homeostasis. Immunodeficient patients with a defect in IL-15 signaling have impaired NK cells 5 . Gene deletion of IL-15 or one of its receptor subunits (α/β/γ) greatly impairs NK cell development in mice 6 .
Studies of various gene knockout mouse models have revealed that multiple transcription factors such as E4BP4, ETS1, ID2, T-BET, EOMES and TOX1 play essential regulatory roles at different stages in NK cell development in mice 7, 8 .
E4BP4 has been shown previously to control early stages of NK cell development 9 .
Knockout of Nfil3 encoding E4BP4 in mice resulted in a substantial reduction of immature (iNK) and mature NK (mNK) cells in BM. Moreover, the expressions of multiple downstream molecules such as EOMES, ID2, GATA3 and IL-15 receptor beta (IL-15RB/CD122) have been shown to be regulated by E4BP4 9, 10 . ETS1 has also been shown to function at early stages of NK cell development to promote the expression of various transcription factors including T-BET and ID2
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. In mNK cells, the expression of ETS1 is required for the expression of different NK cell receptors such as NKp46, Ly49H and Ly49D.
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Deletion of Id2 from mice did not affect the development of NK progenitors (NKP) and iNK. However, the number of mNK was significantly decreased in periphery 12 .
Similarly, T-BET deficient mice have reduced NK cell numbers in the spleen, liver
and peripheral blood with accumulation of NK cells in lymph nodes (LN) and BM 13 .
Furthermore, T-BET regulates the expression of sphingosine-1 phosphate receptor 5 (S1P5) that plays an important role in NK cell recirculation 14 . 
Material and methods

Antibodies, vector constructs and bone marrow cells
The following mAbs were purchased from BD Biosciences (Franklin Lakes, NJ): 
Culture of EL08-1D2 cells
The murine embryonic liver cell line EL08-1D2 was cultured as described before 22 . Lakes, NJ) in some experiments as described in figure legends.
Isolation
NK cell differentiation in vitro
UCB-derived CD34 + cells (15, Hospital-approved animal study.
Quantitative real-time PCR assay and microarray analysis
For RT-qPCR, total RNA was extracted from developing NK cells at various time points by using RNA Clean & Concentrator (Zymo Research, Irvine, CA). All cDNA was generated by using the SuperScript VILO cDNA Synthesis kit (Life Technologies, Carlsbad, CA) and diluted 10-fold for analysis using the 7900HT Fast Real-time PCR System (Applied Biosystems, Foster City, CA). The data were calculated as the C T of target genes normalized to the C T of GAPDH for each sample. Primer sequences of the target genes were: 
Results
TOX2 is increasingly expressed during human NK cell development
It has been previously shown that human CD34 + cells isolated from UCB can differentiate into CD3 -CD56 + NK cells in vitro ( Figure S1A ) 23 . To investigate the changes in gene expression during human NK cell development and to identify novel regulatory pathways, we performed microarray analysis of cultured cells at several time points. We observed a dramatic upregulation of transcription factor TOX2 during in vitro NK cell differentiation, which was confirmed by RT-qPCR ( Figure S1B ). Similar developmental stages can also be identified during in vitro NK cell development from human UCB derived CD34 + cells 22, 24, 25 . stage IV and V) ( Figure 1D ). We also analyzed TOX1 expression in different developmental stages. Although the two transcription factors belong to the same family, the expression profile of TOX1 was different from that of TOX2 in which TOX1 was detectable in earlier developmental stages alongside with ID2.
TOX2 regulates human NK cell maturation and cytotoxicity
To directly determine whether TOX2 regulates NK cell development, we performed Figure S3 ) than those given control CD34 + cells ( Figure 2H ).
We next compared the GFP + CD56 + cell populations derived from control and TOX2-KD CD34 + cells on day 17 to investigate whether TOX2 deficiency affects NK receptor acquisition during cell maturation. As shown in Figure 3A , TOX2-KD did not considerably affect the expression of NKG2A, NKG2D, NKp46, or CD16;
however, the expression of NKp30 was slightly reduced and that of NKp44 largely abolished. We also compared the functional response between control and TOX2-KD cells against K562 targets by CD107a mobilization assay. TOX2-KD greatly reduced the degranulation function of NK cells ( Figure 3B ). We found that the expression of perforin was significantly reduced in TOX2-KD cells. (Figure 3C ).
TOX2 directly regulates the expression of T-BET
We We then investigated if TOX2 directly binds to T-BET promoter region. We designed three different 5'-biotinylated PCR primers to amplify different lengths of the T-BET putative promoter and used them in a TOX2 pull-down assay. We also generated a biotinylated-IL15RB promoter and an irrelevant promoter fragment (ULBP2 promoter) 28 as a control. As shown in Figure 4D , all of the T-BET promoter fragments but not the IL-15RB and ULBP2 promoter captured TOX2 from the lysates prepared from TOX2-WT-transfected 293T cells, indicating the direct interaction between TOX2 and T-BET promoter region (-489-0).
Overexpression of T-BET but not ETS1 rescues the defect of NK cell development from TOX2-knockdown cells
We hypothesized that the regulation of human NK cell maturation by TOX2 is dependent on the expression of T-BET but not the other earlier stage transcription factors such as ETS1, as we have demonstrated before that ETS1 is not a target gene of TOX2 because there was only a slight difference in ETS1 mRNA level between control and TOX2-KD during NK cell development ( Figure 4A ) and that TOX2 had only moderate effect on ETS1 promoter activity ( Figure 4C ). Furthermore, ETS1 is known to be a crucial transcription factor dominating the earlier stages of NK cell differentiation 11 . We overexpressed ETS1 or T-BET in TOX2-KD transduced UCB (Figure 1D ). Moreover, the expression level of TOX1 remained unchanged in TOX2-KD cells ( Figure 4A ).
Collectively, these results suggest that TOX1 and TOX2 play an independent and sequential role in regulation of NK cell development.
Our data suggest that TOX2 is not involved in blood NK lineage commitment.
RT-qPCR analysis revealed that TOX2 mRNA was either low or undetectable from day 0 to day 7 in in vitro NK cell development from UCB-derived CD34 + cells ( Figure S1B ). In addition, silencing of TOX2 gene transcription did not affect the appearance of precursor populations up to early stage III (NKPs) (Figure 2C ,D). In line with the finding that TOX2 directly regulates T-BET transcription, T-BET signaling has been reported to be dispensable for the generation of NKPs 13 . Recent studies revealed that T-BET and EOMES play reciprocal roles in maintaining distinct NK cell lineages in the liver and bone marrow in mice 15, 16 . While the expression of EOMES is essential to maintain the maturity of NK cells in the bone marrow, NK cell development in the liver requires high levels of T-BET with restricted expression of EOMES. Future investigations in the regulatory role of TOX2 in tissue-specific NK-cell development are warranted.
We found that the expression of perforin was greatly reduced in TOX2-KD cells.
Because T-BET has been shown to directly regulate perforin expression 13, 16, 29 , it is likely that the reduced perforin expression was an outcome of decreased T-BET expression in TOX2-KD cells. However, further investigations such as perforin-promoter driven reporter assay are required to rule out whether TOX2 directly controls perforin expression.
In summary, we found that TOX2 is highly expressed in stage IV and stage V of mNK but not in early stages of developing NK cells. In the absence of TOX2, NK cells show substantially reduced T-BET expression, leading to reduced production of 
